214 related articles for article (PubMed ID: 2992092)
1. Recombinant vaccinia virus: immunization against multiple pathogens.
Perkus ME; Piccini A; Lipinskas BR; Paoletti E
Science; 1985 Sep; 229(4717):981-4. PubMed ID: 2992092
[TBL] [Abstract][Full Text] [Related]
2. Recombinant vaccinia viruses as new live vaccines.
Smith GL; Mackett M; Moss B
Biotechnol Genet Eng Rev; 1984; 2():383-407. PubMed ID: 6100668
[No Abstract] [Full Text] [Related]
3. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164
[TBL] [Abstract][Full Text] [Related]
4. Live recombinant vaccines using genetically engineered vaccinia virus.
Paoletti E; Perkus ME; Piccini A
Antiviral Res; 1985; Suppl 1():301-7. PubMed ID: 3866514
[No Abstract] [Full Text] [Related]
5. [Design of a recombinant strain of the vaccinia virus containing an expressible gene for influenza A virus hemagglutinin].
Gibadulin RA; Lazarenko AA; Iuferov VP; Lideman LF; Denisova GF
Vopr Virusol; 1988; 33(3):275-8. PubMed ID: 3176425
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.
Smith GL; Murphy BR; Moss B
Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7155-9. PubMed ID: 6580632
[TBL] [Abstract][Full Text] [Related]
7. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
Smith GL; Mackett M; Moss B
Nature; 1983 Apr; 302(5908):490-5. PubMed ID: 6835382
[TBL] [Abstract][Full Text] [Related]
8. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.
Bennink JR; Yewdell JW; Smith GL; Moller C; Moss B
Nature; 1984 Oct 11-17; 311(5986):578-9. PubMed ID: 6332992
[TBL] [Abstract][Full Text] [Related]
9. Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen.
Flexner C; Murphy BR; Rooney JF; Wohlenberg C; Yuferov V; Notkins AL; Moss B
Nature; 1988 Sep; 335(6187):259-62. PubMed ID: 2842693
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
Zarling JM; Moran PA; Lasky LA; Moss B
J Virol; 1986 Aug; 59(2):506-9. PubMed ID: 3016312
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered poxviruses: a novel approach to the construction of live vaccines.
Paoletti E; Weinberg RL; Davis SW; Davis M
Vaccine; 1984 Sep; 2(3):204-8. PubMed ID: 6099648
[TBL] [Abstract][Full Text] [Related]
13. Live vaccinia virus recombinants expressing herpes simplex virus genes.
Rooney JF; Wohlenberg CR; Moss B; Notkins AL
Rev Infect Dis; 1991; 13 Suppl 11():S898-903. PubMed ID: 1664124
[TBL] [Abstract][Full Text] [Related]
14. Response of dairy calves to vaccinia viruses that express foreign genes.
Gillespie JH; Geissinger C; Scott FW; Higgins WP; Holmes DF; Perkus M; Mercer S; Paoletti E
J Clin Microbiol; 1986 Feb; 23(2):283-8. PubMed ID: 3700615
[TBL] [Abstract][Full Text] [Related]
15. Biological and immunological characterization of influenza virus haemagglutinin expressed from the haemagglutinin locus of vaccinia virus.
Itamura S; Morikawa Y; Shida H; Nerome K; Oya A
J Gen Virol; 1990 Jun; 71 ( Pt 6)():1293-301. PubMed ID: 2351957
[TBL] [Abstract][Full Text] [Related]
16. Genetically engineered herpes simplex virus vaccines.
Watson RJ; Enquist LW
Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
[No Abstract] [Full Text] [Related]
17. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses.
Romero CH; Barrett T; Chamberlain RW; Kitching RP; Fleming M; Black DN
Virology; 1994 Oct; 204(1):425-9. PubMed ID: 8091673
[TBL] [Abstract][Full Text] [Related]
18. Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs.
López N; Scolaro L; Rossi C; Jácamo R; Candurra N; Pujol C; Damonte EB; Franze-Fernández MT
J Gen Virol; 2000 May; 81(Pt 5):1273-81. PubMed ID: 10769070
[TBL] [Abstract][Full Text] [Related]
19. Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins.
Verardi PH; Aziz FH; Ahmad S; Jones LA; Beyene B; Ngotho RN; Wamwayi HM; Yesus MG; Egziabher BG; Yilma TD
J Virol; 2002 Jan; 76(2):484-91. PubMed ID: 11752138
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of antibody formation to the vaccinia virus in human subjects and rabbits in response to the administration of a recombinant vaccinia-hepatitis B vaccine].
Cheliapov NV; Chernos VI; Andzhaparidze OG
Vopr Virusol; 1988; 33(2):175-9. PubMed ID: 2842961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
